IT1199735B - Anticorpi monoclonali cross reattivi e cross-protettivi contro sierotipi di p.aeruginosa - Google Patents

Anticorpi monoclonali cross reattivi e cross-protettivi contro sierotipi di p.aeruginosa

Info

Publication number
IT1199735B
IT1199735B IT22630/86A IT2263086A IT1199735B IT 1199735 B IT1199735 B IT 1199735B IT 22630/86 A IT22630/86 A IT 22630/86A IT 2263086 A IT2263086 A IT 2263086A IT 1199735 B IT1199735 B IT 1199735B
Authority
IT
Italy
Prior art keywords
cross
reactive
antibodies against
monoclonal
protective antibodies
Prior art date
Application number
IT22630/86A
Other languages
English (en)
Other versions
IT8622630A0 (it
Inventor
M Anthony
Mae Siadak
Rosok J
Original Assignee
Genetic Systems Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetic Systems Corp filed Critical Genetic Systems Corp
Publication of IT8622630A0 publication Critical patent/IT8622630A0/it
Application granted granted Critical
Publication of IT1199735B publication Critical patent/IT1199735B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1214—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Pseudomonadaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y10S530/809—Fused cells, e.g. hybridoma

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT22630/86A 1985-12-10 1986-12-10 Anticorpi monoclonali cross reattivi e cross-protettivi contro sierotipi di p.aeruginosa IT1199735B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80739485A 1985-12-10 1985-12-10
US93117986A 1986-11-24 1986-11-24

Publications (2)

Publication Number Publication Date
IT8622630A0 IT8622630A0 (it) 1986-12-10
IT1199735B true IT1199735B (it) 1988-12-30

Family

ID=27123006

Family Applications (1)

Application Number Title Priority Date Filing Date
IT22630/86A IT1199735B (it) 1985-12-10 1986-12-10 Anticorpi monoclonali cross reattivi e cross-protettivi contro sierotipi di p.aeruginosa

Country Status (21)

Country Link
US (4) US5378812A (it)
JP (1) JPH07116237B2 (it)
KR (1) KR910008361B1 (it)
CN (1) CN86108380A (it)
AT (1) AT400441B (it)
BE (1) BE905890A (it)
CH (1) CH677362A5 (it)
DE (1) DE3642095C2 (it)
DK (1) DK594586A (it)
FI (1) FI86377C (it)
FR (1) FR2593826B1 (it)
GB (1) GB2185266B (it)
HU (1) HUT41836A (it)
IE (1) IE59741B1 (it)
IT (1) IT1199735B (it)
LU (1) LU86711A1 (it)
NL (1) NL8603132A (it)
NO (1) NO178718C (it)
NZ (1) NZ218499A (it)
PT (1) PT83894B (it)
SE (1) SE468831B (it)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL81370A (en) * 1986-02-07 1991-06-30 Genetic Systems Corp Pharmaceutical and diagnostic compositions comprising a plurality of human monoclonal antibodies for the treatment of bacterial diseases,methods for the preparation of the compositions and antibodies and kits containing said compositions
DK172840B1 (da) * 1986-07-03 1999-08-09 Genetic Systems Corp Monoklonale antistoffer mod Pseudomonas aeruginosa flagella, farmaceutiske præparater indeholdende sådanne antistoffer og c
EP0256713A3 (en) * 1986-08-06 1989-02-15 Merck & Co. Inc. Therapeutic human antipseudomonas aeruginosa antibodies
EP0327648B1 (en) * 1986-12-15 1993-06-09 MITSUI TOATSU CHEMICALS, Inc. Human monoclonal antibody and drug for prophylaxis and treatment of infectious diseases comprising same as effective ingredient
US5521085A (en) * 1986-12-15 1996-05-28 Mitsui Toatsu Chemicals, Inc. Transformed cell lines producing human monoclonal antibodies specific for Pseudomonas aeruginosa serotypes
WO1990011350A1 (fr) * 1989-03-20 1990-10-04 Mitsui Toatsu Chemicals, Inc. Anticorps monoclonal humain reagissant avec le pseudomonas aeruginosa, cellule produisant cet anticorps, procede de production et preparation pharmaceutique
JPH01197500A (ja) * 1988-01-29 1989-08-09 Sumitomo Chem Co Ltd ヒトモノクローナル抗体
GB2218703B (en) * 1988-05-10 1992-10-28 Sumitomo Chemical Co Human monoclonal antibody to p.aeruginosa: its production and use
CA1341375C (en) * 1988-10-12 2002-07-09 Baxter International Inc. Compositions and methods for the treatment and prevention of gram-negative bacterial infections
EP0382031A3 (en) * 1989-02-10 1991-06-26 Miles Inc. Monoclonal antibodies in immune serum globulin
US4994269A (en) * 1989-03-17 1991-02-19 Miles Inc. Topical use of antibodies for prevention or treatment of pseudomonas infections
JPH02283294A (ja) * 1989-04-24 1990-11-20 Sumitomo Chem Co Ltd ヒトモノクローナル抗体
AU5675790A (en) * 1989-05-09 1990-11-29 Cetus Corporation Human monoclonal antibodies to sero-specific determinants of gram-negative bacteria
US5858728A (en) * 1991-03-13 1999-01-12 Common Services Agency Monoclonal antibody against LPS core
US20030096315A1 (en) 2000-05-03 2003-05-22 Sanders Mitchell C. Device for detecting bacterial contamination and method of use
CA2474458A1 (en) * 2002-01-31 2003-08-07 Mitchell C. Sanders Method for detecting microorganisms
CA2493863A1 (en) * 2002-05-29 2003-12-11 Harvey B. Pollard Arrays identifying genomic and proteomic biomarkers for cystic fibrosis
CN100536836C (zh) * 2002-11-26 2009-09-09 芝加哥大学 预防和治疗微生物介导的上皮紊乱的物质和方法
AU2004225575B2 (en) * 2003-01-31 2008-02-21 Ethicon, Inc. Method for detecting escherichia coli
WO2005042770A2 (en) * 2003-11-03 2005-05-12 Ethicon, Inc. Methods, peptides and biosensors useful for detecting a broad spectrum of bacteria
EP1690875A1 (en) * 2005-02-14 2006-08-16 Kenta Biotech AG Human monoclonal antibody specific for lipopolysaccharides (LPS) of the pseudomonas aeruginosa IATS O11 serotype
US8788049B2 (en) * 2006-05-01 2014-07-22 Bioness Neuromodulation Ltd. Functional electrical stimulation systems
WO2010091189A1 (en) * 2009-02-04 2010-08-12 Kalobios Pharmaceuticals, Inc. Combination antibiotic and antibody therapy for the treatment of pseudomonas aeruginosa infection
US20130022604A1 (en) * 2010-02-18 2013-01-24 Symphogen A/S Antibody against serotype b lipopolysaccharide of pseudomonas aeruginosa
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH652145A5 (de) * 1982-01-22 1985-10-31 Sandoz Ag Verfahren zur in vitro-herstellung von hybridomen welche humane monoklonale antikoerper erzeugen.
US4464465A (en) * 1982-04-05 1984-08-07 Genetic Systems Corporation Cell-driven viral transfer in eukaryotes
JPS59137497A (ja) * 1983-01-20 1984-08-07 ザ・リ−ジエンツ・オブ・ザ・ユニバ−シテイ・オブ・カリフオルニア 抗原特異的免疫グロブリン生産性ヒト／ヒトハイブリド−マ及びその生産する抗体
JPS58216125A (ja) * 1982-06-09 1983-12-15 Asahi Chem Ind Co Ltd ヒト抗体の産生方法
JPS5929622A (ja) * 1982-08-10 1984-02-16 Meiji Seika Kaisha Ltd モノクロ−ナル抗体、その製造法およびその用途
AU585200B2 (en) * 1983-05-06 1989-06-15 Velos Group Monoclonal antibodies reactive with endotoxin core
US4587121A (en) * 1983-06-14 1986-05-06 Miles Laboratories, Inc. High titer Pseudomonas immune serum globulin
US5179018A (en) * 1983-10-14 1993-01-12 Centocor, Inc. Mamalian monoclonal antibodies against endotoxin of gram-negative bacteria
WO1985002685A1 (en) * 1983-12-12 1985-06-20 Meru, Inc. Method and materials for the identification of lipopolysaccharide producing microorganisms
US4683196A (en) * 1983-12-12 1987-07-28 Meru, Inc. Method and materials for the identification of lipopolysaccharide producing microorganisms
JP2565303B2 (ja) * 1984-05-25 1996-12-18 三井東圧化学株式会社 緑膿菌感染症の予防治療剤
JPS60248625A (ja) * 1984-05-25 1985-12-09 Mitsui Toatsu Chem Inc 抗緑膿菌モノクロ−ナル抗体、その製法ならびに用途
US4834975A (en) * 1984-05-25 1989-05-30 Genetics Corporation Human monoclonal antibodies to serotypic lipopolysaccharide determinants on gram-negative bacteria and their production
DE3426903A1 (de) * 1984-07-20 1986-01-23 Biotest Pharma GmbH, 6000 Frankfurt Eine immunglobulinpraeparation in kombination mit einer anderen pharmakologisch wirksamen praeparation zur verwendung bei der behandlung von krankheiten
WO1986003754A1 (en) * 1984-12-26 1986-07-03 Teijin Limited Anti-pseudomonas aeruginosa human monoclonal antibody
US4677070A (en) * 1985-04-26 1987-06-30 Cetus Corporation Pseudomonas aeruginosa exotoxin A antibodies, their preparation and use
JPS6229175A (ja) * 1985-07-29 1987-02-07 Nippon Telegr & Teleph Corp <Ntt> 電界効果型トランジスタの製造方法
EP0211352B1 (en) * 1985-08-01 1994-03-16 Miles Inc. Protective antibodies to serotypic determinants of flagellar antigens
US4772464A (en) * 1985-08-01 1988-09-20 Miles Laboratories, Inc. Protective antibodies to serotypic determinants of flagellar antigens
US4777136A (en) * 1985-09-27 1988-10-11 The Regents Of The University Of California Monoclonal antibody reactive with Pseudomonas Aeruginosa
US4970070A (en) * 1986-02-07 1990-11-13 Genetic Systems Corporation Protective monoclonal antibody compositions for infections due to group B streptococcus
DK172840B1 (da) * 1986-07-03 1999-08-09 Genetic Systems Corp Monoklonale antistoffer mod Pseudomonas aeruginosa flagella, farmaceutiske præparater indeholdende sådanne antistoffer og c
EP0256713A3 (en) * 1986-08-06 1989-02-15 Merck & Co. Inc. Therapeutic human antipseudomonas aeruginosa antibodies

Also Published As

Publication number Publication date
LU86711A1 (fr) 1988-07-14
FI86377C (fi) 1992-08-25
NO178718B (no) 1996-02-12
FI865027A (fi) 1987-06-11
SE8605295L (sv) 1987-06-11
DK594586D0 (da) 1986-12-10
PT83894B (pt) 1989-07-31
HUT41836A (en) 1987-05-28
ATA328286A (de) 1995-05-15
US5628996A (en) 1997-05-13
NO864971L (no) 1987-06-11
CH677362A5 (it) 1991-05-15
GB2185266A (en) 1987-07-15
CN86108380A (zh) 1987-10-28
US5627067A (en) 1997-05-06
DK594586A (da) 1987-06-11
JPS62187417A (ja) 1987-08-15
SE8605295D0 (sv) 1986-12-10
NL8603132A (nl) 1987-07-01
NO178718C (no) 1996-05-22
FR2593826A1 (fr) 1987-08-07
NO864971D0 (no) 1986-12-10
NZ218499A (en) 1990-04-26
GB8629540D0 (en) 1987-01-21
AT400441B (de) 1995-12-27
FR2593826B1 (fr) 1990-11-16
KR870005648A (ko) 1987-07-06
FI86377B (fi) 1992-05-15
PT83894A (en) 1987-01-01
JPH07116237B2 (ja) 1995-12-13
BE905890A (fr) 1987-06-10
IE863230L (en) 1987-06-10
FI865027A0 (fi) 1986-12-10
IE59741B1 (en) 1994-03-23
GB2185266B (en) 1990-09-05
IT8622630A0 (it) 1986-12-10
US5378812A (en) 1995-01-03
KR910008361B1 (ko) 1991-10-12
US5662905A (en) 1997-09-02
DE3642095C2 (de) 1998-10-01
DE3642095A1 (de) 1987-07-02
SE468831B (sv) 1993-03-29

Similar Documents

Publication Publication Date Title
IT1199735B (it) Anticorpi monoclonali cross reattivi e cross-protettivi contro sierotipi di p.aeruginosa
DE3584559D1 (de) Therapeutische antikoerpermittelkonjugate.
DE68914244T2 (de) Monoklonaler Antikörper.
DK488882A (da) Iodothyronin-immunogen-konjugat, antistof mod konjugatet samt iodothyronin-derivat
DE69018801T2 (de) Chimärischer anti-cae-antikörper.
DE3382572D1 (de) Antikoerper-verbindungen.
DK666389A (da) Monoklonalt antistof
FR2694767B1 (fr) Anticorps monoclonaux anti-IL6R, et leurs applications.
DE3879452T2 (de) Chimaere antikoerper.
DE3854502T2 (de) Gegen hiv-antigene spezifischer monoklonaler antikörper.
NO822853L (no) Antigenbestemmelse.
NO159884C (no) Monoklonalt antistoff.
DE3885355T2 (de) Monoklonale Antikörper.
DK63187A (da) Krydsbeskyttende monoklonale antistofpraeparater
FI861691A0 (fi) En ny tumoerassocierad antigen.
DE3583341D1 (de) Leberwurm-antigene.
NO894444D0 (no) Anti-fucosylceramid monoklonalt antistoff.
DE3780256T2 (de) Anti-pci-monoklonaler antikoerper.
DE3586808D1 (de) L-thyroxin erkennende monoklonale antikoerper.
NO873488D0 (no) Monoklonale antistoffer.
DE3584280D1 (de) Monoklonaler antikoerper gegen menschlichen krebs.
DK474189A (da) Monoklonalt antistof
NO890116L (no) Monoklonale antistoffer.
DE68910956D1 (de) Mit toxin modifizierter antikörper.
DE69023717D1 (de) Monoklonaler Antikörper.

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19961227